Fully Covered


Visit: Finimize

What’s going on?

Warren Buffett’s been comparing the markets: his conglomerate Berkshire Hathaway announced on Monday that it’s agreed to buy insurance company Alleghany for $11.6 billion.

What does this mean?

Buffett’s been searching for Berkshire Hathaway’s next big investment for a while now, and said just last month that he was having a hard time finding it. But it looks like perseverance paid off: Berkshire announced on Monday that it’s agreed to buy fellow conglomerate Alleghany – whose core business is property and casualty insurance – for $11.6 billion in cash, 29% more than the company was worth on average over the past 30 days.

The deal – Berkshire’s biggest since 2016 – isn’t its first move into insurance. The company owns plenty of firms – like Geico, one of America’s biggest car insurers – in the space, and the industry’s already played a big role in growing Berkshire into the conglomerate it is today, boasting a market value of more than $750 billion.

Why should I care?

The bigger picture: Talk about cash to splash.

$11.6 billion sure sounds like a ludicrous amount of money, but it counts for less than 10% of Berkshire’s nearly $150 billion in cash. So even after making one of its five biggest deals ever and pledging to keep $30 billion in cash last month, Berkshire still has about $100 billion left that it could splash on even bigger deals in the future.

Zooming out: Software’s looking good.

Berkshire isn’t the only one making deals this week: private equity (PE) firm Thoma Bravo announced it’s buying Anaplan – a company that provides forecasting software to businesses – for $10.7 billion. The deal’s the latest in a bunch of PE takeovers in the software sector, including that of cyber security company McAfee last year. Some reckon it could be a sign that market volatility and higher costs of borrowing haven’t put firms off the industry, so more deals could be on their way this year.

Originally Posted March 21, 2022 – Fully Covered

Disclosure: Interactive Brokers

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Finimize and is being posted with permission from Finimize. The views expressed in this material are solely those of the author and/or Finimize and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

In accordance with EU regulation: The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.

Any trading symbols displayed are for illustrative purposes only and are not intended to portray recommendations.